Q&A with the ADSC Providers Webinar Slides (2/16/2022)
This document contains the slides from the Adult Down Syndrome Center's webinar in which the…
Rigsby RigsbyMarch 10, 2022
Q&A with the ADSC Providers Webinar Recording (2/16/2022)
The video below is a recording of a webinar presented by Brian Chicoine, MD, Katie…
How is Alzheimer’s disease diagnosed in a person with Down syndrome?
Alzheimer’s disease is a progressive neurological condition. It is a type of dementia. Alzheimer’s disease…
Rigsby RigsbyMarch 8, 2022
Medical Care Guidelines for Adults with Down syndrome
The Global Down Syndrome Foundation Medical Care Guidelines for Adults with Down Syndrome Workgroup (GLOBAL…
Rigsby RigsbyJanuary 27, 2022
The State of Alzheimer’s Research, with Dr Marcia Ratner & Dr James Hendrix
Dr. Marcia Ratner & Dr. James Hendrix discuss recent developments in Alzheimer’s research.Source: Dr. Marcia…
Rigsby RigsbyDecember 3, 2021
Health Care for Adults with Down Syndrome
In this video, Stephanie L. Santoro, M.D. discusses health care for adults with Down syndrome.…
Rigsby RigsbyNovember 8, 2021
Why Patient Voices Are So Critical to the Development and Initial Approval of New Drugs
This blogpost from a former FDA insider on the power of the patient helps us…
Rigsby RigsbyOctober 27, 2021
LuMind IDSC signs on to NTG statement re: Aduhelm
“It is unknown to what degree aducanumab (Aduhelm) may help people with Down syndrome, as…
Rigsby RigsbyOctober 27, 2021
LuMind IDSC and Other National Groups Urge CMS to Include DS Community in Alzheimer’s Drugs Coverage
LuMind IDSC and Other National Groups Urge CMS to Include DS Community in Alzheimer’s Drugs Coverage
LuMind IDSC has joined the National Down Syndrome Society (NDSS) and The National Task Group…
Rigsby RigsbyOctober 27, 2021
FDA Approves Biogen’s Aduhelm, the First New Drug for Alzheimer’s Disease Since 2003
Today marks an important milestone in Alzheimer’s disease research with the approval by the FDA…
Rigsby RigsbyOctober 27, 2021